# Medical Therapy of Prostatic Symptoms

> **NCT00021814** · PHASE3 · COMPLETED · sponsor: **National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)** · enrollment: 3407 (actual)

## Conditions studied

- Prostatic Hyperplasia
- Prostatic Hypertrophy, Benign

## Interventions

- **DRUG:** Doxazosin
- **DRUG:** Finasteride
- **DRUG:** Doxazosin placebo
- **DRUG:** Finasteride placebo

## Key facts

- **NCT ID:** NCT00021814
- **Lead sponsor:** National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- **Sponsor class:** NIH
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1995-12
- **Primary completion:** 2001-11-30
- **Final completion:** 2001-11-30
- **Target enrollment:** 3407 (ACTUAL)
- **Last updated:** 2018-09-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00021814

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00021814, "Medical Therapy of Prostatic Symptoms". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT00021814. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*